Commit To Purchase Blueprint Medicines Corp At $55, Earn 14.8% Annualized Using Options
September 24, 2018 at 11:52 AM EDT
Investors considering a purchase of Blueprint Medicines Corp (BPMC) shares, but tentative about paying the going market price of $69.60/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2019 put at the $55 strike, which has a bid at the time of this writing of $4.60..